1
项与 CD123/CD33 CART(Essen Biotech) 相关的临床试验Sequential CAR-T Cell Infusion Targeting CD33 and CD123 for Refractory/Relapsed Acute Myeloid Leukaemia
This is an open, single-arm, clinical study to evaluate the efficacy and safety of chimeric antigen receptor T cell immunotherapy (CAR-T) targeting CD33 or CD123 or both sequentially in the treatment of Acute Myelocytic Leukemia.
100 项与 CD123/CD33 CART(Essen Biotech) 相关的临床结果
100 项与 CD123/CD33 CART(Essen Biotech) 相关的转化医学
100 项与 CD123/CD33 CART(Essen Biotech) 相关的专利(医药)
100 项与 CD123/CD33 CART(Essen Biotech) 相关的药物交易